| Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria |
|
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag |
|
Haematologica |
Aplastic Anemia |
| Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study |
|
BMJ Supportive & Palliative Care |
Myelodysplastic Syndromes (MDS) |
| Eltrombopag in children with severe aplastic anemia |
|
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
| Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria |
|
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes |
|
Hematology/oncology clinics of North America |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
| Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia |
|
Transplantation and Cellular Therapy |
Aplastic Anemia, Graft Versus Host Disease (GVHD) |
| Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) |
|
Cancers |
Chronic Myelomonocytic Leukaemia (CMML), Myelodysplastic Syndromes (MDS) |
| Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS |
|
Bone Marrow Transplantation |
Myelodysplastic Syndromes (MDS) |
| Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria |
|
The New England Journal of Medicine |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
